MSITF (Medical Services International) 5-Year Yield-on-Cost %: 0.00 (As of Jun. 25, 2026)


What is Medical Services International 5-Year Yield-on-Cost %?

Medical Services International MSITF -99.00% 5-Year Yield-on-Cost % is 0.00 as of Jun. 25, 2026.

Medical Services International's yield on cost for the quarter that ended in . 20 was 0.00.


The historical rank and industry rank for Medical Services International's 5-Year Yield-on-Cost % or its related term are showing as below:



MSITF's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.96
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Medical Services International  (OTCPK:MSITF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Medical Services International 5-Year Yield-on-Cost % Related Terms

MSITF vs FUTU, ADK, DVCR: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Medical Services International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Services International 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medical Services International's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medical Services International's 5-Year Yield-on-Cost % falls into.


Medical Services International 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medical Services International is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Medical Services International (MSITF) has a 5-Year Yield-on-Cost % of 0.00 as of Jun. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medical Services International and its competitors.
Is Medical Services International's 5-Year Yield-on-Cost % too high?
Medical Services International's current 5-Year Yield-on-Cost % is 0.00.
How does Medical Services International's 5-Year Yield-on-Cost % compare to FUTU and ADK?
Medical Services International's 5-Year Yield-on-Cost % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median 5-Year Yield-on-Cost % is 2.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.96, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medical Services International and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Services International's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Services International stock overvalued right now?
Medical Services International (MSITF) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medical Services International (MSITF), the current 5-Year Yield-on-Cost % is 0.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Services International Business Description

Address 5643 Riverbend Road, P.O. Box 59144, Edmonton, AB, CAN, T6H 5Y3
Medical Services International Inc provides medical diagnostic services and dialysis for Anguilla and surrounding islands. The company offers dialysis for travellers, manufactures, under contract, a home test kit for HIV and Hep C and contracts to perform clinical studies.